Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits
Johnson Johnson Offers Up to $5.5 Billion in Baby Powder Cancer Settlement
Healfromzero.com – Johnson Johnson offers up to $5.5 billion in a landmark agreement to resolve tens of thousands of lawsuits filed in the United States. These legal actions allege that Johnson & Johnson’s talcum powder-based products, including its iconic baby powder, caused ovarian cancer in users. The pharmaceutical and consumer goods giant has proposed paying plaintiffs up to $3 billion by 2027, with any remaining amounts distributed after 2028. In a statement released on Monday, the company expressed hope that these settlements would bring closure to what it described as “meritless 15-year litigation.” The comprehensive settlement proposal addresses approximately 76,000 individual claims brought against the New Jersey-based corporation.
Settlement Requirements and Legal Context
For the settlement to move forward, it must receive approval from law firms representing at least 95% of all claimants, according to Johnson & Johnson’s official statement. The company has faced persistent allegations for years that talcum powder used in its products contained cancer-causing asbestos particles. Despite these accusations, Johnson & Johnson has consistently maintained that its products are safe and have not caused cancer. Some scientific research indicates that women who use talc in the genital area may experience an increased risk of ovarian cancer, though other studies have found no such connection.
In 2020, Johnson & Johnson discontinued its talc-based baby powder in North America, transitioning to a cornstarch-based formula. The company extended this change to global markets in 2023. In both instances, Johnson & Johnson stated that the decision aimed to simplify its product portfolio while defending the safety of its talc-based offerings. Erik Haas, the company’s vice president of litigation, emphasized that the lawsuits “lack scientific merit.” He noted that while Johnson & Johnson remained confident it would have ultimately prevailed in further litigation, the settlement allows the company to resolve the matter comprehensively.
Plaintiff Perspectives and Recent Developments
Chris Seeger, an attorney representing several plaintiffs, characterized the settlement as “a fair measure of long-delayed justice” in a Monday statement. Speaking to CNN, Seeger indicated that the settlement value remains uncapped and could potentially increase. He did not immediately address Johnson & Johnson’s assertion that the cases lacked a scientific foundation. Last week, a federal judge questioned approximately 69,000 of the claims, requiring plaintiffs to present specific evidence connecting their ovarian cancer diagnoses to Johnson & Johnson’s baby powder and other talc-based products, according to Reuters reporting.
The legal battles against Johnson & Johnson have produced mixed results. The company has faced substantial verdicts in certain cases while winning others where juries found no liability. In October, a Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, a rare cancer typically associated with asbestos exposure. The company, which has seen some awards reduced on appeal, announced plans to challenge the most recent decision, calling the verdict “egregious and unconstitutional.”
Frequently Asked Questions
When will Johnson Johnson offers up to $5.5 billion in settlements be finalized? The settlement requires approval from law firms representing at least 95% of claimants. Once approved, the first $3 billion will be paid by 2027, with remaining amounts distributed after 2028.
How many lawsuits are included in the Johnson & Johnson baby powder settlement? The settlement covers approximately 76,000 claims alleging that Johnson & Johnson’s talcum powder products caused ovarian cancer.
Why did Johnson & Johnson stop selling talc-based baby powder? Johnson & Johnson discontinued its talc-based baby powder in North America in 2020 and globally in 2023 to simplify its product portfolio while maintaining that its talc products remain safe.
What is the current status of the Johnson Johnson offers up to $5.5 billion settlement? The settlement proposal awaits approval from plaintiff law firms representing at least 95% of claimants. The total value is uncapped and could potentially increase beyond the initial $5.5 billion offer.